MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-07
DOI
10.1038/s41598-019-43355-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-15b promotes proliferation and invasion of non-small cell lung carcinoma cells by directly targeting TIMP2
- (2017) Haowen Wang et al. ONCOLOGY REPORTS
- Progression and metastasis of lung cancer
- (2016) Helmut H. Popper CANCER AND METASTASIS REVIEWS
- MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis
- (2016) Jianwei Tian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN
- (2016) Hiroshi Egawa et al. Scientific Reports
- MicroRNA (miRNA) in cancer
- (2015) Kaladhar B Reddy Cancer Cell International
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Value of Tissue Inhibitor of Metalloproteinase-2 Expression in Patients with Non–Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2015) Lin Zhu et al. PLoS One
- TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells
- (2015) Dimitra Bourboulia et al. Oncotarget
- Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic
- (2014) William G. Stetler-Stevenson et al. CONNECTIVE TISSUE RESEARCH
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- sFRP1 Inhibits Epithelial–Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cell Line
- (2013) Jin Ren et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Antagonism of VEGF-A-induced increase in vascular permeability by an integrin 3 1-Shp-1-cAMP/PKA pathway
- (2012) S. H. Kim et al. BLOOD
- TIMP-2 Targets Tumor-associated Myeloid Suppressor Cells With Effects in Cancer Immune Dysfunction and Angiogenesis
- (2012) Liliana Guedez et al. JOURNAL OF IMMUNOTHERAPY
- EGFR–TKI resistant non-small cell lung cancer (NSCLC): New developments and implications for future treatment
- (2012) Wolfram Brugger et al. LUNG CANCER
- Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma
- (2012) Pushpinder Kaur et al. TUMOR BIOLOGY
- Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
- (2011) Peter Friedl et al. CELL
- The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis
- (2010) Qian Qian et al. CANCER INVESTIGATION
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
- (2008) W. G. Stetler-Stevenson Science Signaling
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started